A federal judge in Texas ruled on Friday that President Joe Biden's administration had wrongly interpreted an Obamacare provision as barring health care providers from discriminating against gay and transgender people.
Officials from U.S. President Joe Biden's administration are finalizing a request this week for about $10 billion in public health funds by the end of the year, The Washington Post reported on Monday.
Nearly three years into the COVID-19 pandemic, leaders of G20 countries are gathering on the Indonesian resort island of Bali with strict testing and masking requirements, even though such measures have been largely dropped in some member countries.
U.S. Food and Drug Administration staff reviewers on Monday raised concerns over unclear benefits of Ardelyx Inc's drug for kidney disease patients, but the company's shares rose 20% on expectations over a possible approval.
Spain's competition watchdog has fined Italy-based drugmaker Leadiant Biosciences 10.3 million euros ($10.63 million) for selling an orphan drug at an excessive price, it said on Monday.
The British government said on Monday it would contribute 1 billion pounds ($1.18 billion) to the Global Fund to fight AIDS, tuberculosis and malaria, more than six weeks after other countries made their commitments.
Satsuma Pharmaceuticals Inc said on Monday its experimental lead treatment for acute migraine headaches failed to meet the main goals of a late-stage trial, sending its shares down nearly 83% in premarket trade.
South Africa reported an outbreak of highly pathogenic H5N2 bird flu on a farm in the eastern part of the country, the Paris-based World Organisation for Animal Health (WOAH) said on Monday, citing a report from local authorities.
Denmark has reported an outbreak of highly pathogenic H5N1 avian influenza, or bird flu, on a turkey farm, the Paris-based World Organisation for Animal Health (WOAH) said on Monday.
Moderna Inc said on Monday its Omicron-tailored vaccines produced a better immune response against the BA.4/5 subvariants in a mid-to-late stage study, when given as a booster dose, compared with its original shot.
